FDA approves first new UTI drug in decades
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections (UTIs), the first such drug approved in decades and the first in a new class of medications. British pharmaceutical company GSK announced Tuesday that the FDA had approved its oral antibiotic Blujepa for treating uncomplicated urinary tract infections
Verywell Health on MSN6d
Can a UTI Go Away Without Treatment?An uncomplicated urinary tracti infection (UTI) could go away on its own, but waiting increases the risk of symptoms turning ...
The company said Blujepa represents a significant advancement in UTI treatment, as it is the first new class of oral antibiotics for uUTIs in nearly three decades. In trials, the drug was ...
New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for improved treatment. UTIs are one of the most prevalent bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback